HEMATOLOGY

Mouse Models of Myelodysplastic Syndromes

Sep 18, 2017 by in HEMATOLOGY Comments Off on Mouse Models of Myelodysplastic Syndromes

Three general approaches have been used to model myelodysplastic syndrome (MDS) in mice, including treatment with mutagens or carcinogens, xenotransplantation of human MDS cells, and genetic engineering of mouse hematopoietic…

read more

Immunosuppression for Myelodysplastic Syndrome: How Bench to Bedside to Bench Research Led to Success

Sep 18, 2017 by in HEMATOLOGY Comments Off on Immunosuppression for Myelodysplastic Syndrome: How Bench to Bedside to Bench Research Led to Success

Laboratory evidence and clinical evidence suggest that some patients with myelodysplastic syndrome (MDS) have immunologically mediated disease. This article describes the laboratory evidence supporting a role for the immune system…

read more

Epigenetic Changes in the Myelodysplastic Syndrome

Sep 18, 2017 by in HEMATOLOGY Comments Off on Epigenetic Changes in the Myelodysplastic Syndrome

Epigenetic mechanisms, such as DNA methylation and histone modifications, drive stable, clonally propagated changes in gene expression and can therefore serve as molecular mediators of pathway dysfunction in neoplasia. Myelodysplastic…

read more

The Genetic Basis of Myelodysplastic Syndromes

Sep 18, 2017 by in HEMATOLOGY Comments Off on The Genetic Basis of Myelodysplastic Syndromes

Myelodysplastic syndrome (MDS) disorders are clonal diseases that often carry stereotypic chromosomal abnormalities. A smaller proportion of cases harbor point mutations that activate oncogenes or inactivate tumor suppressor genes. New…

read more

The Epidemiology of Myelodysplastic Syndromes

Sep 18, 2017 by in HEMATOLOGY Comments Off on The Epidemiology of Myelodysplastic Syndromes

The incidence of the myelodysplastic syndromes (MDS) in the United States is reported as 3.4 per 100,000 people, translating to over 10,000 new diagnoses annually. This figure is considered to…

read more

Management of Cancer-Related Pain

Sep 18, 2017 by in HEMATOLOGY Comments Off on Management of Cancer-Related Pain

Patients and families struggling with cancer fear pain more than any other physical symptom. There are also significant barriers to optimal pain management in the emergency setting, including lack of…

read more

Myeloproliferative Disorders and the Hyperviscosity Syndrome

Sep 18, 2017 by in HEMATOLOGY Comments Off on Myeloproliferative Disorders and the Hyperviscosity Syndrome

Myeloproliferative disorders and the serum hyperviscosity syndrome can rapidly manifest with emergent presentations. Hyperviscosity occurs from pathologic elevations of either the cellular or acellular (protein) fractions of the circulating blood….

read more

Neutropenic Enterocolitis

Sep 18, 2017 by in HEMATOLOGY Comments Off on Neutropenic Enterocolitis

Neutropenic enterocolitis, also known as typhlitis or ileocecal syndrome, is a rare, but important, complication of neutropenia associated with malignancy. It occurs as a result of chemotherapeutic damage to the…

read more

Renal Complications in Oncologic Patients

Sep 18, 2017 by in HEMATOLOGY Comments Off on Renal Complications in Oncologic Patients

Acute renal failure (ARF) can be one of the many complications associated with malignancy and, unfortunately, often harbors a worse prognosis for the afflicted patient. Insult to the kidneys can…

read more
Get Clinical Tree app for offline access